You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
- 2. Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
- 3. Interpretable machine learning model integrating contrast-enhanced CT environmental radiomics and clinicopathological features for predicting postoperative recurrence in lung adenocarcinoma: a retrospective pilot study
- 4. SystImmune, Inc. to Present New izalontamab brengitecan (iza-bren) Data in Small Cell Lung Cancer and Non-Small Cell Lung Cancer with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations at ASCO Congress 2025
- 5. Piers Morgan Asks Jason Miller About Possibility of Charging Jill Biden With ‘Elder Abuse'
- 6. Watch: 'Dilbert' Creator Scott Adams Says Trump Called, Twice, to Wish Him Well After Cancer Diagnosis
- 7. Biden's Prostate Cancer Likely Grew Undetected for Years, Experts Say
- 8. Dilbert cartoonist reveals Trump personally reached out following his terminal cancer announcement
- 9. Hotspots and frontiers of the relationship between gastric cancer and cancer-associated fibroblasts: a bibliometric analysis
- 10. Inflammation as a key mediator: linking triglyceride-glucose index to prognosis in non-muscle-invasive bladder cancer
Last updated at 21:34 GMT
Hot News Makers
Health/Pharma Companies
-
4231.00
-
3230.59
-
2193.55
-
2103.50
-
998.55
-
982.30
-
935.63
-
499.28
-
341.61
-
307.02
Drugs, Treatments, Trials
-
8028.71
-
2583.78
-
637.80
-
377.96
-
353.42
-
154.01
-
149.94
-
149.11
-
122.91
-
119.58
Last updated at 21:10 GMT
